Try our Advanced Search for more refined results
New Jersey - May, 2011
40 articles
- Rutgers Gets Antitrust Suit Over Asparagus IP Tossed
- Pfizer Ends Patent War Over Generic Neurontin
- Cravath Reps Ashland In $3.2B Chemical Maker Buy
- NJ Sues Ex-Newark Mayor Over Use Of Campaign Funds
- NJ Judge Trims Pet Flea Treatment Class Actions
- Jackson Hewitt's False Ad Claims V. H&R Block Trimmed
- NJ Withdraws From Regional Carbon Trading Program
- ETS Settles Government Overcharge Claims For $4.6M
- Sharp's Trademark Suit Over Dell Monitors Moves On
- Plaintiffs, Claims Added To $100M Bayer Sex Bias Suit
- AstraZeneca Adds Intellipharmaceutics To Seroquel Row
- Watson Expands Generics Biz With $562M Specifar Buy
- Ex-UBS Client Gets Probation In Tax Shelter Case
- Arch Loses Bid To Kill H20's Skin Product Mold Suit
- Suits Spur Debate On Outside Investment In Law Firms
- Hendrix Estate, Sax Player Settle 'Georgia Blues' Suit
- CORRECTED: Mylan's Inequitable Conduct Claim Axed In Vytorin IP Suit
- 3rd Circ. Keeps NJ's Suit V. Merrill In State Court
- NJ Class Suit Targets Bayer Probiotics Products
- Cravath Reps Rosetta In $575M Sale To Publicis
- Chromium Action Survives Honeywell's Review Bid
- Atty Unsatisfied With Sex Enhancement Drug Wins Round
- AT&T, Cingular Settle With Marsh In Bid-Rigging MDL
- Nutella False Marketing Action To Remain In Calif.
- US Withdraws Objections To Military Site Settlement
- Lilly Claims Zydus Broke Deal In Strattera Row
- Hertz Ups Dollar Thrifty Bid To $2.25B
- Wright Medical In Hot Seat Over $8M Kickbacks Settlement
- Merck Unit Sues Sandoz Over Generic Noxafil
- Mortgage Insurer Shakes JPMorgan Loan Coverage Suit
- Jazz Hits Roxane With Patent Suit Over Xyrem
- Investor Tries To Stop LabCorp's $85M Orchid Buyout
- Investors Sue J&J Board Over $78M In Settlements
- Takeda Sues Mylan Over Prevacid Patents
- Pfizer, Eon Settle Neurontin Patent Claims
- Taro Sues Suven To Block Generic Lice Treatment
- NJ Co. Settles EPA Cleanup Claims For $19M
- AstraZeneca Ends Seroquel Case Against Biovail
- DOT Says NJ Must Repay $271M Spent On Tunnel Project
- Medicines Co. Sues Dr. Reddy's Over Generic Angiomax